News for 'Sun Pharma'

Netra Mantena's Fab Bridal Looks

Netra Mantena's Fab Bridal Looks

Rediff.com25 Nov 2025

From beautifully decorated venues glowing under fairy lights to celebrity guests' dance performances, every function felt straight out of a Bollywood dream sequence. The biggest scene stealer, however, was Netra's wedding wardrobe.

Sensex drops over 331 points on last-minute selling

Sensex drops over 331 points on last-minute selling

Rediff.com24 Nov 2025

Among Sensex firms, Bharat Electronics, Mahindra & Mahindra, Tata Steel, UltraTech Cement, Bajaj Finserv and Tata Motors Passenger Vehicles were the major laggards. However, Tech Mahindra, Asian Paints, Infosys, Adani Ports, Sun Pharma and HDFC Bank were the gainers.

Not neutral, India is on the side of peace, Modi tells Putin

Not neutral, India is on the side of peace, Modi tells Putin

Rediff.com5 Dec 2025

Prime Minister Narendra Modi strongly supported efforts to end the war in Ukraine and conveyed to Russian President Vladimir Putin that India will stand shoulder-to-shoulder in all peace efforts to find an amicable solution to the conflict.

India terms EU envoys' article unusual before key Putin visit

India terms EU envoys' article unusual before key Putin visit

Rediff.com3 Dec 2025

India and Russia are poised to sign multiple agreements to bolster cooperation in various sectors, including trade and healthcare, during Russian President Vladimir Putin's visit to New Delhi. Discussions will also address the Ukraine conflict and efforts to increase Indian exports to Russia.

Trump slaps 100% tariffs on imported pharma products

Trump slaps 100% tariffs on imported pharma products

Rediff.com26 Sep 2025

United States President Donald Trump on Friday announced that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies are building production facilities in the US.

Sensex jumps over 513 points on buying in IT stocks

Sensex jumps over 513 points on buying in IT stocks

Rediff.com19 Nov 2025

From the Sensex pack, HCL Tech, Infosys, Tata Consultancy Services, Hindustan Unilever, Sun Pharma and Titan were among the biggest gainers. In contrast, Tata Motors Passenger Vehicles, Maruti, Adani Ports and Bajaj Finance were among the laggards.

JioHotStar Is Investing 4K Cr In South!

JioHotStar Is Investing 4K Cr In South!

Rediff.com10 Dec 2025

The platform has seen a growth of 70% in watch time for South content, which is more than the national average.The South has outperformed the rest of India in subscription depth, retention and connected TV adoption.

Sensex jumps 1,022.50 points; Nifty inches near record high

Sensex jumps 1,022.50 points; Nifty inches near record high

Rediff.com26 Nov 2025

Among Sensex firms, Bajaj Finserv, Bajaj Finance, Tata Steel, Reliance Industries, Sun Pharma, Tata Motors Passenger Vehicles, Axis Bank and Infosys were among the major gainers. Bharti Airtel and Asian Paints emerged as the laggards from the pack.

The Lady Who Designed The Billionaire Wedding

The Lady Who Designed The Billionaire Wedding

Rediff.com9 Dec 2025

When Chennai-based Wedding Designer Ambika Gupta first received a brief for a destination wedding in Udaipur, she had no idea it would turn into one of the most high-profile celebrations of the season.

Sensex climbs 304 pts on buying in metal, auto and pharma shares

Sensex climbs 304 pts on buying in metal, auto and pharma shares

Rediff.com13 Aug 2025

Among Sensex firms, Bharat Electronics, Eternal, Mahindra & Mahindra, Kotak Mahindra Bank, Tata Motors and Power Grid were the gainers. However, Adani Ports, ITC, UltraTech Cement and Titan were among the laggards.

Startups go vertical in India's qcom race

Startups go vertical in India's qcom race

Rediff.com24 Oct 2025

As the quick commerce (qcom) race hots up, a new model - vertical qcom - is gaining investor attention. Unlike horizontal players such as Blinkit, Zepto, and Swiggy Instamart, which stock everything from groceries to gifts and gadgets, vertical platforms focus on depth over breadth.

Indian pharma firms not copying products of Swiss cos: Goyal

Indian pharma firms not copying products of Swiss cos: Goyal

Rediff.com10 Jun 2025

Dismissing allegations that Indian phacosrmaceutical companies copy products of Swiss firms, Commerce and Industry Minister Piyush Goyal on Tuesday said it is a long-standing myth and India respects intellectual property rights and never steals technology from others. He said that Swiss pharmaceutical companies have not shown even a single instance that Indian companies have illegally copied any of their trademarks or patents or copyrighted technology.

Putin to land in Delhi soon, Modi to host private dinner

Putin to land in Delhi soon, Modi to host private dinner

Rediff.com4 Dec 2025

Prime Minister Narendra Modi will host Russian President Vladimir Putin for a private dinner and summit, focusing on defence, trade, and geopolitical issues, including the Ukraine conflict and the impact of US sanctions.

Rupee Fall: Who Stands To Gain?

Rupee Fall: Who Stands To Gain?

Rediff.com25 Nov 2025

So far this year, the rupee has fallen by 4.2 per cent, the worst among its Asian peers.

Modi and Putin: Hug in airport, ride in car, dinner at 7, LKM

Modi and Putin: Hug in airport, ride in car, dinner at 7, LKM

Rediff.com5 Dec 2025

Russian President Vladimir Putin arrived in New Delhi for a two-day visit focused on strengthening ties with India, including defense cooperation and trade, amidst a changing geopolitical landscape.

How To Choose MFs Smartly

How To Choose MFs Smartly

Rediff.com3 Dec 2025

Investors who constantly hop between 'top-performing' funds often end up earning far lower returns than the very funds they invest in -- simply because they enter late and exit early. Best investors don't chase returns, they chase discipline, says Ramalingam Kalirajan.

Sensex rises 317 pts on gains in auto, pharma shares

Sensex rises 317 pts on gains in auto, pharma shares

Rediff.com15 Jul 2025

Stock markets snapped the four-day falling streak on Tuesday with the benchmark Sensex rebounding by 317 points on buying in auto and pharma shares amid a decline in retail inflation to a more than six-year low, nearing the RBI's comfort zone. The 30-share BSE Sensex climbed 317.45 points or 0.39 per cent to settle at 82,570.91. During the day, it jumped 490.16 points or 0.59 per cent to 82,743.62. The 50-share NSE Nifty edged higher by 113.50 points or 0.45 per cent to 25,195.80.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Sensex jumps 595 points on strong global cues

Sensex jumps 595 points on strong global cues

Rediff.com12 Nov 2025

From the Sensex pack, Asian Paints, Tech Mahindra, Tata Consultancy Services, Bajaj Finserv, Adani Ports, HCL Technologies, Bharti Airtel, Infosys, Trent, Reliance Industries, UltraTech Cement, Sun Pharmaceuticals, Eternal, Titan and Bajaj Finance were the gainers. On the other hand, Tata Steel, Tata Motors Passenger Vehicles, Tata Motors Commercial Vehicles, Bharat Electronics, Kotak Mahindra Bank and PowerGrid were the laggards.

Weak guidance may hit Sun Pharma in FY26

Weak guidance may hit Sun Pharma in FY26

Rediff.com1 Jun 2025

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, Sun Pharmaceutical Industries (Sun Pharma), was under pressure on Friday due to a muted guidance. The company has guided for a high single-digit revenue growth for FY26, which is below what the Street was working with.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Infant dies in MP after taking Ayurvedic cough syrup

Infant dies in MP after taking Ayurvedic cough syrup

Rediff.com31 Oct 2025

A five-month-old girl has died in Chhindwara district in Madhya Pradesh allegedly after consuming an Ayurvedic cough syrup and a medicinal powder, an official said on Friday.

Stock markets rally on US Fed rate cut hopes, fresh foreign fund inflows

Stock markets rally on US Fed rate cut hopes, fresh foreign fund inflows

Rediff.com29 Oct 2025

From the Sensex firms, Adani Ports, NTPC, Power Grid, HCL Tech, Tata Steel, Sun Pharma, Trent and Asian Paints were among the major gainers. However, Bharat Electronics, Eternal, Mahindra & Mahindra and Maruti were among the laggards.

Mankind taps OpenAI to institutionalise AI in ops

Mankind taps OpenAI to institutionalise AI in ops

Rediff.com18 Sep 2025

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.

Alerted Centre, MP govt about toxic cough syrup: TN minister

Alerted Centre, MP govt about toxic cough syrup: TN minister

Rediff.com10 Oct 2025

Tamil Nadu government alerted Madhya Pradesh and the Union Health Ministry about the presence of a toxic substance in Coldrif cough syrup, averting a major tragedy, according to state Health Minister Ma Subramanian.

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Rediff.com30 Oct 2025

Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at Rs 1,353.37 crore for the second quarter ended September 30, 2025. The company, which had posted a consolidated net profit of Rs 1,305.01 crore in the second quarter of the last fiscal year, said its managing director & global CEO, Umang Vohra, has decided not to seek re-appointment upon completion of his current term on March 31, 2026, Cipla Ltd said in a regulatory filing.

Samvat 2082: Investors likely to see up to 15% returns from equities

Samvat 2082: Investors likely to see up to 15% returns from equities

Rediff.com5 Nov 2025

After a year of modest returns, equity investors may anticipate gains of 10-15 per cent in Samvat 2082, which began on October 21. Although valuations have moderated from their peaks a year earlier, they remain above long-term averages, potentially limiting sharp upsides.

'From March 2026, India Should Resume Long-Term Uptrend'

'From March 2026, India Should Resume Long-Term Uptrend'

Rediff.com29 Sep 2025

'Indian markets may underperform global peers for the next two quarters.' 'But beyond that, India should catch up and resume its long-term growth path.'

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Rediff.com4 Oct 2025

The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Kaysons Pharma following reports of children's deaths allegedly linked to contaminated cough syrup.

Will Tata Sons Get RBI Relief?

Will Tata Sons Get RBI Relief?

Rediff.com24 Oct 2025

Tata Sons, now debt-free, has asked the RBI to drop its 'upper-layer NBFC' tag and allow it to stay private.

Sensex falls 344 pts amid profit-taking, foreign fund outflows

Sensex falls 344 pts amid profit-taking, foreign fund outflows

Rediff.com24 Oct 2025

Among Sensex firms, Hindustan Unilever dropped the most by 3.20 per cent. UltraTech Cement, Kotak Mahindra Bank, Adani Ports, Titan, HDFC Bank and Axis Bank were also among the laggards. However, Bharti Airtel, ICICI Bank, Bharat Electronics and Sun Pharma were among the gainers.

600 Crore IPO Fees Light Up Diwali For I-Bankers

600 Crore IPO Fees Light Up Diwali For I-Bankers

Rediff.com24 Oct 2025

With several $500 million-plus deals in the pipeline -- including ICICI Prudential AMC, Lenskart, PhonePe, Groww, PhysicsWallah, Meesho, Pine Labs, and Zepto -- investment bankers look poised for another year of hefty bonuses in 2025.

Selling in blue-chips RIL, HDFC Bank drag Sensex down by 153 points

Selling in blue-chips RIL, HDFC Bank drag Sensex down by 153 points

Rediff.com8 Oct 2025

Among Sensex firms, Tata Motors, Mahindra & Mahindra, Bharat Electronics, UltraTech Cement, Trent, Sun Pharma, Power Grid and Reliance Industries were the major laggards. However, Titan, Infosys, Tata Consultancy Services, HCL Tech and Tech Mahindra were among the biggest gainers.

15 killed, 34 hurt in explosion at Telangana pharma plant

15 killed, 34 hurt in explosion at Telangana pharma plant

Rediff.com1 Jul 2025

At least 12 people died and 34 persons were injured in a pharma plant explosion in Sangareddy district of Telangana on Monday, State Minister Damodara Raja Narasimha said.

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Rediff.com12 Apr 2025

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning trade on the back of an announcement that a court ruling has cleared the deck for the India's largest pharmaceutical company to launch its alopecia drug Leqselvi in the United States.

Steel industry flags price pressure from cheap imports

Steel industry flags price pressure from cheap imports

Rediff.com27 Oct 2025

Ahead of the key meeting called by the steel ministry with the industry captains on Monday to discuss the impact of rising steel imports, companies have raised the issue of cheaper 'substandard' inflows from China, Vietnam, and South Korea, saying they are setting the benchmark for domestic prices and squeezing the profitability of Indian producers.

'We Have Become The Largest Eyewear Brand In Asia'

'We Have Become The Largest Eyewear Brand In Asia'

Rediff.com5 Nov 2025

'India needs at least 70,000 to 80,000 eyewear stores; our 2,000 stores are just a drop in the ocean.'

Toxic cough syrup kills 2 more kids in MP, toll rises to 22

Toxic cough syrup kills 2 more kids in MP, toll rises to 22

Rediff.com9 Oct 2025

The death toll from contaminated cough syrup in Madhya Pradesh has risen to 22, with two more children succumbing to kidney infections. An investigation is underway, and arrests have been made.

Maharashtra FDA warns against THIS cough syrup

Maharashtra FDA warns against THIS cough syrup

Rediff.com6 Oct 2025

The Maharashtra Food and Drug Administration (FDA) on Monday appealed to the people to immediately stop the sale or use of a specific batch of Coldrif syrup, following child deaths in Madhya Pradesh and Rajasthan allegedly linked to the medicine.